Topics and Expertise: tuberculosis

Data-driven drug dosing speeds tuberculosis treatment to four months

A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.

Research points to individualized treatments for curing TB

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Rada Savic, PhD

Vice Dean & Professor

I co-lead the School’s plans for developing graduate education programs in the computational and experimental sciences, along with Brian Shoichet, PhD. These programs are geared toward giving the School’s PharmD students greater career opportunities throughout biomedicine.

As a faculty member in...